Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2022-02-07 00:00:00 ET · period of report 2022-02-03 · accession 0001209191-22-007348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-07 | 2022-02-03 | ALXO | Pons Jaume | Pres, CEO, Dir | M - OptEx | $1.46 | +24.2K | 456.7K | +6% | +$35.2K |
| DM | 2022-02-07 | 2022-02-03 | ALXO | Pons Jaume | Pres, CEO, Dir | M - OptEx | $0.00 | -24.2K | 6,128 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | M | A | 12,254 | $1.91 | 468,978 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-03 | M | A | 11,900 | $0.99 | 456,724 | D | — | — | (F1) Includes 226 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-02-03 | M | D | 11,900 | $0.00 | 230,279 | D | $0.99 · — to 2027-03-30 | 11,900 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2022-02-03 | M | D | 12,254 | $0.00 | 6,128 | D | $1.91 · — to 2029-09-12 | 12,254 Common Stock | (F3) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019. |